Monday, May 23, 2016 12:37:40 AM
Looks like the AZN/TPIV cleared things up as it now has Tapimmune as a collaborator.
It says that that trial should have primary outcome in 1 year.
The latter trial run by tpiv says 3 years.
Guess I'll be sitting on my hands for the next 3 years waiting for some positive data.
I wonder when Mayo will begin recruiting the 280 patients. Thst could take a while with that amount of patients.
I need to quit smoking before I find myself in one of these trials
Recent MRKR News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
